Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
1982-12-16
pubmed:abstractText
An improved method for measurement of 3-methylhistidine in blood samples has been used to assess efflux of 3-methylhistidine from the leg in cancer patients experiencing weight loss. Three control groups were studied: malnourished depleted patients without cancer; comparatively well-nourished but acutely ill patients; and well-nourished controls, hospitalized for elective surgery, who showed no symptoms of metabolic disease. Well-nourished controls and acutely ill patients had a statistically significant release of 3-methylhistidine [1.92 +/- 0.40 (S.E.) nmol/min/100 g leg tissue and 0.93 +/- 0.32 nmol/min/100 g, respectively], but cancer patients and malnourished noncancer patients had insignificant efflux. When nutritional support was provided, noncancer patients abolished their previously negative tyrosine balance and increased the efflux of 3-methylhistidine; however, cancer patients as a group continued to show a negative tyrosine balance, and the efflux of 3-methylhistidine continued to decrease further in them. The results in this study demonstrate that weight loss in clinical cancer is not dependent on increased skeletal muscle protein degradation, not even at an early stage of the disease. It seems likely that decreased protein synthesis is a more important factor.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0008-5472
pubmed:author
pubmed:issnType
Print
pubmed:volume
42
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4807-11
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed:year
1982
pubmed:articleTitle
Efflux of 3-methylhistidine from the leg in cancer patients who experience weight loss.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't